Endoscopic Devices - Serbia | Statista Market Forecast

Revenue in the Endoscopic Devices market market in Serbia is anticipated to reach US$29.76m in 2024.
It is expected that revenue will exhibit an annual growth rate (CAGR 2024-2029) of 7.96%, leading to a market volume of US$43.65m by 2029.
In a global context, the majority of revenue will be generated the United States, which is projected to reach US$10.39bn in 2024.
In Serbia, the increasing demand for minimally invasive procedures is driving innovation and growth in the endoscopic devices segment of the medical technology market.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Serbia is witnessing moderate growth, influenced by factors such as advancements in technology, increasing prevalence of gastrointestinal disorders, and a growing emphasis on minimally invasive procedures among healthcare providers and patients.

Customer preferences: There is a noticeable shift among consumers in Serbia towards preferring minimally invasive medical procedures, reflecting a growing awareness of the benefits associated with endoscopic techniques. This trend is driven by an aging population and rising rates of gastrointestinal disorders, prompting patients to seek out advanced treatment options that promise quicker recovery times and reduced postoperative discomfort. Additionally, cultural attitudes emphasizing health and wellness are leading to increased demand for innovative endoscopic devices, further reshaping the healthcare landscape.

Trends in the market: In Serbia, the Endoscopic Devices Market is experiencing a surge in demand for advanced minimally invasive surgical options, driven by an aging population and increasing prevalence of gastrointestinal disorders. Healthcare providers are increasingly adopting sophisticated endoscopic techniques, which promise not only quicker recovery times but also reduced rates of complications. This trend reflects a broader cultural shift towards prioritizing health and wellness, with patients actively seeking innovative solutions. Industry stakeholders, including manufacturers and healthcare facilities, must adapt to this evolving landscape by investing in research and development, enhancing training programs, and expanding access to cutting-edge endoscopic technologies.

Local special circumstances: In Serbia, the Endoscopic Devices Market is uniquely influenced by the country's healthcare infrastructure and regulatory environment. The government has been actively investing in healthcare modernization, facilitating the adoption of advanced medical technologies. Additionally, Serbia's geographical location as a hub for medical tourism is driving demand for high-quality endoscopic procedures. Cultural attitudes towards health are shifting, with patients increasingly favoring minimally invasive treatments. This confluence of local factors enhances the market's growth potential while presenting opportunities for innovation and collaboration among industry players.

Underlying macroeconomic factors: The Endoscopic Devices Market in Serbia is significantly shaped by macroeconomic factors such as national economic stability, healthcare funding, and global market trends. Serbia's commitment to improving its healthcare infrastructure, backed by strategic investments and favorable fiscal policies, is fostering a conducive environment for the adoption of advanced endoscopic technologies. Furthermore, the rising prevalence of chronic diseases and an aging population amplify the demand for minimally invasive procedures, aligning with global trends towards patient-centered care. As Serbia strengthens its position as a medical tourism hub, the influx of foreign patients is expected to further stimulate market growth and innovation in endoscopic devices.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.